Global Human Growth Hormone Market Growth 2023-2029

Global Human Growth Hormone Market Growth 2023-2029

Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.

LPI (LP Information)' newest research report, the “Human Growth Hormone Industry Forecast” looks at past sales and reviews total world Human Growth Hormone sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Growth Hormone sales for 2023 through 2029. With Human Growth Hormone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Growth Hormone industry.

This Insight Report provides a comprehensive analysis of the global Human Growth Hormone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Growth Hormone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Human Growth Hormone market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Growth Hormone and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Growth Hormone.

The global Human Growth Hormone market size is projected to grow from US$ 4358.3 million in 2022 to US$ 5555.1 million in 2029; it is expected to grow at a CAGR of 5555.1 from 2023 to 2029.

For industry structure analysis, the Human Growth Hormone industry is very concentrated. These manufacturers ranging from large multinational corporations to small privately owned companies compete in this industry. The top five producers include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono and F. Hoffmann-La Roche, account for more than 80% of the revenue market. Regionally, North America is the biggest production value area of valves, also the leader in the whole Human Growth Hormone industry.

North America occupied 42% of the production market. It is followed by Europe and China, which respectively have around 27% and 16% of the global total industry. Other countries have a small amount of production. Geographically, North America was the largest consumption market in the world, which took about 44.59% of the global consumption volume.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Growth Hormone market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Powder
Solvent

Segmentation by application
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age
SHOX Deficiency
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human Growth Hormone market?

What factors are driving Human Growth Hormone market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Human Growth Hormone market opportunities vary by end market size?

How does Human Growth Hormone break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.